Passage Bio, Inc.
PASG
$0.3117
-$0.0145-4.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.73M | -19.34M | -15.99M | -16.71M | -16.76M |
| Total Depreciation and Amortization | 719.00K | 759.00K | 797.00K | 806.00K | 807.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.11M | 5.77M | 1.72M | 1.15M | 722.00K |
| Change in Net Operating Assets | -5.55M | 5.36M | 339.00K | -4.18M | -4.29M |
| Cash from Operations | -8.44M | -7.45M | -13.14M | -18.93M | -19.52M |
| Capital Expenditure | -14.00K | -20.00K | -- | -- | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.69M | 14.99M | 1.05M | 25.25M | 7.61M |
| Cash from Investing | 13.68M | 14.97M | 1.05M | 25.25M | 7.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 47.00K | 0.00 | 85.00K | 8.74M | 46.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 47.00K | 0.00 | 85.00K | 8.74M | 46.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.28M | 7.52M | -12.00M | 15.06M | -11.87M |